Sharing our knowledge of melanoma on the global stage

Sharing our knowledge of melanoma on the global stage

15 April 2021

More than 2,000 clinicians and researchers from across the globe will unite online this weekend for the virtual 10th World Congress of Melanoma in conjunction with the 17th EADO Congress.

As leaders in the field of melanoma, many clinicians and researchers from Melanoma Institute Australia (MIA) will be sharing their knowledge as this congress provides an opportunity to educate clinicians on the latest developments in our understanding and treatment of skin cancer.

Here are just a handful of the areas of melanoma research that we will be presenting on:

  • Renowned pathologist and MIA’s Co-Medical Director, Prof Richard Scolyer, will discuss how we can predict the likelihood that a patient’s disease will return by examining the molecular profile of their melanoma.
  • Medical Oncologist and MIA’s Co-Medical Director Prof Georgina Long AO will be delivering a keynote address discussing if a cure for advanced melanoma is on the horizon. She will review the recent advancements in drug development to treat advanced melanoma, as well as outline the challenges we still face to overcome drug resistance. Prof Long will also highlight the importance of getting our prevention messaging across if we truly want to reach our goal of zero deaths from melanoma. 
  • Translational researcher Prof Helen Rizos will be reviewing how circulating DNA in the bloodstream can be used as a marker to monitor disease and treatment response in patients with advanced melanoma. This minimally invasive technique can help monitor patients in real-time and is proving to be a valuable new tool to support the clinical care of patients with melanoma.
  • Dermatologist Prof Diona Damian will be presenting an overview of nicotinamide (vitamin B3) as a preventative measure to reduce the incidence of non-melanoma skin cancers in high-risk patients.
  • Using clinical data alone can help predict which patients will respond well to treatment with immunotherapy. However, when Dr James Wilmott and our team of lab researchers examined biopsies taken from patients before immunotherapy, they found that biopsies showing higher numbers of immune cells touching the melanoma were associated with response and tumour shrinkage. Dr Wilmott will share these findings which will ultimately help select the ideal therapies for patients and will be incorporated into our Personalised Immunotherapy Platform.

Through the combined sharing of knowledge, it is inspiring to see the global commitment to enhancing our understanding of melanoma that will ultimately improve the care of melanoma patients.

#10thWCM

Olivia Vivian nominates MIA as Charity Partner on Channel 9's Celebrity Apprentice.
02 Dec 2020

Olivia Vivian nominates MIA as Charity Partner on Channel 9's Celebrity Apprentice.

A Ninja Warrior legend and Olympic gymnast, Olivia knows first hand the devastating impact of melanoma.

Tags: melanoma
It's 'Game On Mole' this summer!
01 Dec 2020

It's 'Game On Mole' this summer!

All Australians are urged to join the fight against melanoma this summer. 

Tags: melanoma
Prof Richard Scolyer named Outstanding Cancer Researcher of the Year  
27 Nov 2020

Prof Richard Scolyer named Outstanding Cancer Researcher of the Year  

The ground-breaking work of MIA's Co-Medical Director Prof Richard Scolyer has been recognised with NSW’s highest accolade for cancer research. 

Tags: melanoma
Dr James Wilmott wins 2020 Wildfire Highly Cited Publication Award
24 Nov 2020

Dr James Wilmott wins 2020 Wildfire Highly Cited Publication Award

A landmark study led by MIA's Dr Willmott is making a difference to melanoma treatment around the globe.

Tags: melanoma
MIA researchers feature on prestigious Highly Cited Researchers 2020 List
18 Nov 2020

MIA researchers feature on prestigious Highly Cited Researchers 2020 List

The highly anticipated annual list is the “who’s who” of the scientific elite from across the globe.

Tags: melanoma
Game On Mole is back this summer!
13 Nov 2020

Game On Mole is back this summer!

The uniquely Aussie awareness campaign ‘Game On Mole’ is back for its second year – with a new look but same important message.

Tags: melanoma
RCPA recognition for Professor Richard Scolyer.
12 Nov 2020

RCPA recognition for Professor Richard Scolyer.

Professor Richard Scolyer receives The Royal College of Pathologists of Australasia Distinguished Fellow Award.

Tags: melanoma
Professor Georgina Long hands on baton of SMR Presidency
31 Oct 2020

Professor Georgina Long hands on baton of SMR Presidency

Professor Long cites as a highlight of her 2-year Presidency, the phenomenal research output by SMR members who have continued to lead the cancer field despite the impact of COVID-19.

Tags: melanoma
City2Surf 2020
11 Sep 2020

City2Surf 2020

Join in the fun of the virtual event, and together we can run over melanoma!

Tags: melanoma
Top melanoma experts from MIA
10 Sep 2020

Top melanoma experts at MIA

Melanoma Institute Australia features prominently in the latest ‘Expertise in Melanoma’ world rankings, released by Expertscape.

Tags: melanoma
Top melanoma experts from MIA
10 Sep 2020

Top melanoma experts from MIA

Melanoma Institute Australia features prominently in the latest ‘Expertise in Melanoma’ world rankings, released by Expertscape.

Tags: melanoma
Melanoma Supportive Care Needs research study. 
03 Sep 2020

Melanoma Supportive Care Needs research study. 

Participate in our online survey and help us understand the support needs of melanoma patients and carers.

Tags: melanoma
New data reveals long-term benefit of adjuvant therapy for Stage III melanoma.
03 Sep 2020

Research reveals long-term benefit of adjuvant therapy for Stage III melanoma

Updated results published in the New England Journal of Medicine.
Tags: melanoma
New data reveals long-term benefit of adjuvant therapy for Stage III melanoma.
03 Sep 2020

New data reveals long-term benefit of adjuvant therapy for Stage III melanoma.

Updated results published in the New England Journal of Medicine.
Tags: melanoma
New online melanoma risk calculators critical to saving lives
28 Aug 2020

New online melanoma risk calculators critical to saving lives

Clinicians and their patients now have access to three online risk calculators developed by researchers at Melanoma Institute Australia.

Tags: melanoma
Professor Richard Scolyer receives University of Sydney Alumni Award.
24 Aug 2020

Professor Richard Scolyer receives University of Sydney Alumni Award.

MIA's Co-Medical Director Professor Richard Scolyer has received The University of Sydney Alumni Award for International Achievement.

Tags: melanoma
Uniting together despite the distance
21 Aug 2020

Uniting together despite the distance

More than 120 MIA clinicians, researchers and staff came together online to share research highlights.

Tags: melanoma
Professor Richard Scolyer recognised in The Pathologist's 2020 Power List.
03 Aug 2020

Professor Richard Scolyer recognised in The Pathologist's 2020 Power List.

For the 2nd consecutive year, MIA's Co-Medical Director Professor Richard Scolyer has been selected in the top 100 best, brightest, and most powerful advocates of pathology by The Pathologist.

Tags: melanoma
Important Update: Masks required at Poche Centre
24 Jul 2020

Important Update: Masks required at Poche Centre

As of Monday 27th July all patients and carers/family members coming into The Poche Centre will be required to bring their own mask. 

Tags: melanoma
A Critical Nexus:The Clinician and the Researcher.
14 Jul 2020

A Critical Nexus:The Clinician and the Researcher.

In a recent issue of Cancer Cell journal, Prof Georgina Long AO and Prof Richard Scolyer discuss the challenge of bringing together clinical work and scientific research to underpin successful cancer research.    

Tags: melanoma